Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses

Adoptive therapy with regulatory T cells or tolerance-inducing antigen (Ag)-presenting cells is innovative and promising therapeutic approach to control undesired and harmful activation of the immune system, as observed in autoimmune diseases, solid organ and bone marrow transplantation. One of the...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2017-12, Vol.8, p.1870-1870
Main Authors: Ten Brinke, Anja, Marek-Trzonkowska, Natalia, Mansilla, Maria J, Turksma, Annelies W, Piekarska, Karolina, Iwaszkiewicz-Grześ, Dorota, Passerini, Laura, Locafaro, Grazia, Puñet-Ortiz, Joan, van Ham, S Marieke, Hernandez-Fuentes, Maria P, Martínez-Cáceres, Eva M, Gregori, Silvia
Format: Article
Language:English
Subjects:
antigen-specific
Immunology
monitoring
proliferation
T cells
tolerance
transplantation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Adoptive therapy with regulatory T cells or tolerance-inducing antigen (Ag)-presenting cells is innovative and promising therapeutic approach to control undesired and harmful activation of the immune system, as observed in autoimmune diseases, solid organ and bone marrow transplantation. One of the critical issues to elucidate the mechanisms responsible for success or failure of these therapies and define the specificity of the therapy is the evaluation of the Ag-specific T-cell responses. Several efforts have been made to develop suitable and reproducible assays. Here, we focus on dye-based proliferation assays. We highlight with practical examples the fundamental issues to take into consideration for implementation of an effective and sensitive dye-based proliferation assay to monitor Ag-specific responses in patients. The most critical points were used to design a road map to set up and analyze the optimal assay to assess Ag-specific T-cell responses in patients undergoing different treatments. This is the first step to optimize monitoring of tolerance induction, allowing comparison of outcomes of different clinical studies. The road map can also be applied to other therapeutic interventions, not limited to tolerance induction therapies, in which Ag-specific T-cell responses are relevant such as vaccination approaches and cancer immunotherapy.
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2017.01870